Spherix Global Insights

October 26, 2020

Ocrevus Use Still Growing in Europe But Challenges on Horizon, Spherix Reports

From: Multiple Sclerosis News Today By: Marta Figueiredo Prescriptions of Roche’s Ocrevus (ocrelizumab) among multiple sclerosis (MS) patients initiating or switching a disease-modifying…